# Invesco Biotechnology & Genome ETF (PBE) — Overview

PBE · NYSE · Fund

Canonical page: https://www.lighthorse.io/tickers/pbe

## Price

Last close $98.65 on Oct 15, 2026. 52-week range $71.62 – $98.73.

## Fund profile

PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.

| Metric | Value |
| --- | --- |
| Issuer | Invesco Capital Management LLC |
| Industry | Healthcare |
| Inception | Jun 23, 2005 |
| Assets under management | $428.0M |
| Expense ratio | 0.59% |
| Net asset value | $98.61 (as of Oct 15, 2026) |
| Distributions | Quarterly |
| Leverage | 1x |

## Frequently Asked Questions

### What is Invesco Biotechnology & Genome ETF (PBE)?

PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.

### What is PBE's expense ratio?

Invesco Biotechnology & Genome ETF charges an annual expense ratio of 0.59%. The fund is issued by Invesco Capital Management LLC.

### How large is PBE?

Invesco Biotechnology & Genome ETF manages $428.0M in assets and has traded since Jun 23, 2005.

### How do I buy shares of Invesco Biotechnology & Genome ETF (PBE)?

PBE trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).